WELLS FARGO & COMPANY/MN - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 53 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$361
-36.4%
247
-0.4%
0.00%
Q2 2023$568
+161.8%
248
+4.2%
0.00%
Q1 2023$217
+8.5%
238
+1.3%
0.00%
Q4 2022$200235
+2.6%
0.00%
Q3 2022$0229
+5.0%
0.00%
Q2 2022$0
-100.0%
218
+19.8%
0.00%
Q3 2021$1,000182
+10.3%
0.00%
Q2 2021$0
-100.0%
165
+0.6%
0.00%
Q1 2021$1,000164
+57.7%
0.00%
Q4 2020$0104
+6.1%
0.00%
Q3 2020$098
+24.1%
0.00%
Q2 2020$0790.0%0.00%
Q1 2020$0
-100.0%
79
-88.3%
0.00%
Q2 2019$3,000
-97.0%
676
-97.3%
0.00%
Q1 2019$101,000
+9.8%
25,015
-0.1%
0.00%
Q4 2018$92,000
+170.6%
25,031
+528.6%
0.00%
Q3 2018$34,000
-12.8%
3,982
+12.1%
0.00%
Q2 2018$39,000
+5.4%
3,552
+11.6%
0.00%
Q1 2018$37,000
+12.1%
3,182
+0.6%
0.00%
Q4 2017$33,000
-70.3%
3,163
-54.4%
0.00%
Q3 2017$111,000
+170.7%
6,940
+103.8%
0.00%
Q2 2017$41,000
-42.3%
3,406
+0.2%
0.00%
Q1 2017$71,000
+446.2%
3,400
+277.8%
0.00%
Q4 2016$13,000
-43.5%
900
-35.7%
0.00%
Q3 2016$23,000
+130.0%
1,400
+100.0%
0.00%
Q2 2016$10,0007000.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$8,746,0001.82%
Telemetry Investments, L.L.C. 263,975$705,0000.97%
CHI Advisors LLC 719,132$1,920,0000.45%
BVF INC/IL 3,678,626$9,822,0000.37%
EcoR1 Capital, LLC 3,579,377$9,557,0000.36%
Orbimed Advisors 8,053,298$21,502,0000.22%
Stonepine Capital Management, LLC 46,886$125,0000.06%
Ikarian Capital, LLC 100,000$267,0000.02%
ALGERT GLOBAL LLC 19,737$53,0000.02%
Windsor Creek Advisors, LLC 14,786$39,0000.01%
View complete list of CORVUS PHARMACEUTICALS INC shareholders